You are here: Industry Insights > monoclonal antibody

News List

A Review of Leukemia Targeting Drugs in 2016: Small Molecule Drugs and Monoclonal Antibody Drugs Par en-cphi
February 10, 2017
Leukemia is a clonal disease caused due to mutation of human hematopoietic stem cells, can cause symptoms like bleeding, anemia, organ infiltration and intestinal function failure of patients, and is a human disease of great harm.
Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Jou firstwordpharma
January 26, 2017
Voyager Therapeutics, Inc. announced the publication of new preclinical data highlighting markedly reduced tau pathology including neurofibrillary tangles and neurodegeneration...
TG Therapeutics Announces Orphan Drug Designation for the Combination of TG-1101 and TGR-1202 for th firstwordpharma
January 25, 2017
TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation covering the combination of TG-1101 (ublituximab).
Kymab appoints Dr Arndt Schottelius as Executive Vice President Research & Development firstwordpharma
January 24, 2017
Kymab Group Limited announced today the appointment of Dr Arndt Schottelius as its first Executive Vice President Research & Development.
Sanofi licences ImmuNext autoimmune disease drug pharmatimes
January 17, 2017
Sanofi and ImmuNext have announced an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases including lupus and multiple sclerosis.
Pfizer, AbCellera in Multi-Target Research Pact contractpharma
January 06, 2017
Aims to generate lead antibody candidates using AbCellera’s mAb discovery platform.

Previous page 1 2 3 4 5 6 Next page